Recent Posts
- Amolyt Pharma to Host Hybrid Key Opinion Leader Event on Eneboparatide, a PTHR1 Agonist Entering phase 3 for the Treatement of Hypoparathyroidism, in Chicago on June 16, 2023
- Primo1D Teams Up with Decathlon to Bring Garment Tracingto the Recycling Sector Thanks to its E- Thread™ Technology
- Amolyt Pharma Launches Public Awareness Campaign to Honor World Hypoparathyroidism Awareness Day
- Ciliatech raises €3.5M in Series A funding
- Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow-up
Archives
- June 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- October 2022
- September 2022
- August 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- October 2021
- September 2021
- August 2021
- July 2021
- May 2021
- April 2021
- March 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- July 2020
- April 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- July 2019
- March 2019
- February 2019
- December 2018
- November 2018
- December 2017
- September 2017
- April 2017